Healthcare Business

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Sorrento Therapeutics shares jumped on Thursday after the company announced that it received approval from the FDA for its COVID-19 treatment.
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday. 
On Tuesday, Canaccord Genuity reiterated its rating on Atara Biotherapeutics and raised its wildly bullish target price even higher.
The announcement of positive topline results in a late-stage epilepsy trial prompted a rally in Marinus Pharmaceuticals shares on Tuesday.
Companies winning approval from the FDA or beating a trial are expected in some cases. If investors already have priced this news into the stock, when it actually comes around they tend to sell the...
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
Cassava Sciences reported good results from a mid-stage study of its sumifilam treatment for Alzheimer's disease. Shares soared on the news.
Telemedicine platform provider GoodRx intends to price more than 34 million shares for an initial public offering valued up to more than $1 billion.
Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in one of the biggest deals to go down in the health care sector this year.
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
After Satsuma Pharmaceuticals reported disappointing late-stage results from its migraine treatment, and its shares were absolutely crushed Thursday morning. 
The FDA has approved Innoviva's treatment of asthma and for patients with chronic obstructive pulmonary disease, the company announced, giving shares a boost early Thursday.
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that causes COVID-19.